Alpha 2.0
Login Register
» Authors » Patricia Garcia Ramirez

Patricia Garcia Ramirez

Explore the profile of Patricia Garcia Ramirez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 3
Followers 0
Related Specialties
Oncology
General Medicine
Top 10 Co-Authors
Jose Maria Aspa Cilleruelo
Lucia Castilla Garcia
Marta Callejas Charavia
Miguel Angel Ortega
Santiago Osorio Prendes
Rosalia Alonso Trillo
Julio Garcia-Suarez
Jorge Monserrat Sanz
Jose Luis Diez-Martin
Patricia Font Lopez
Published In
Cancers (Basel)
Med Clin (Barc)
Clin Case Rep
Med Clin (Engl Ed)
Vaccines (Basel)
Affiliations
Soon will be listed here.
Recent Articles
1.
SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment
Garcia Ramirez P, Callejas Charavia M, Oliva Martin R, Gomez La Hoz A, Ortega M, Garcia Suarez J, et al.
Vaccines (Basel) . 2024 Sep; 12(9). PMID: 39339993
Background: Patients with B-lymphocyte malignancies (BCMs) receiving B-lymphocyte-targeted therapies have increased risk of severe COVID-19 outcomes and impaired antibody response to SARS-CoV-2 mRNA vaccination in comparison to non-hematologic oncologic patients...
2.
Isatuximab-carfilzomib-dexamethasone immediately after failing of the quadruplet Daratumumab-bortezomib-lenalidomide-dexamethasone (Dara-VRD): Striking response with no washout in a newly diagnosed multiple myeloma
Gil-Fernandez J, Garcia Ramirez P, Callejas Charavia M
Clin Case Rep . 2024 Jan; 12(1):e8449. PMID: 38268620
Biochemical evolution of serum IgG-Kappa monoclonal component during the first line with VRD (x1), DARA-VRD (x4), and the second line with ISA-KD (x4).
3.
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
Martinez-Lopez J, DE LA Cruz J, Gil-Manso R, Jimenez Yuste V, Aspa-Cilleruelo J, Escobar C, et al.
Cancers (Basel) . 2024 Jan; 16(2). PMID: 38254867
A greater understanding of clinical trends in COVID-19 outcomes among patients with hematologic malignancies (HM) over the course of the pandemic, particularly the Omicron era, is needed. This ongoing, observational,...
4.
Novel Candidate and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
Andres-Zayas C, Suarez-Gonzalez J, Chicano-Lavilla M, Oreiro M, Rodriguez-Macias G, Font Lopez P, et al.
Cancers (Basel) . 2023 Feb; 15(3). PMID: 36765901
The familial occurrence of hematological malignancies has been underappreciated. Recent studies suggest that up to 15% of adults with myeloid neoplasms carry germline pathogenic variants in cancer-predisposing genes. This study...
5.
Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients
Garcia Ramirez P, Castilla Garcia L, Aspa Cilleruelo J
Med Clin (Engl Ed) . 2022 May; 158(10):497-498. PMID: 35530262
No abstract available.
6.
[Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients]
Garcia Ramirez P, Castilla Garcia L, Aspa Cilleruelo J
Med Clin (Barc) . 2021 Oct; 158(10):497-498. PMID: 34666903
No abstract available.